PNPLA3—A Potential Therapeutic Target for Personalized Treatment of Chronic Liver Disease
Patatin-like phospholipase domain-containing protein 3 (PNPLA3) is a lipid droplet-associated protein that has been shown to have hydrolase activity toward triglycerides and retinyl esters. The first evidence of PNPLA3 being associated with fatty liver disease was revealed by a genome-wide associati...
Main Author: | Xiaocheng Charlie Dong |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-12-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmed.2019.00304/full |
Similar Items
-
Clinical-morphological parallels of the PNPLA3 gene polymorphism in patients with nonalcoholic fatty liver disease
by: A S Tikhomirova, et al.
Published: (2018-02-01) -
ANALYSIS OF POLYMORPHIC OPTIONS OF THE ENOS, PNPLA3, CD14 GENES AT ALCOHOLIC LIVER DISEASE
by: V.Ye. Molodtsov, et al.
Published: (2019-06-01) -
The structure of Haplotypes and Diplotypes in the PNPLA3 gene in the Yakut Population
by: Khariton A. Kurtanov, et al.
Published: (2020-12-01) -
The rs738409 polymorphism of the PNPLA3 gene is associated with hepatic steatosis and fibrosis in Brazilian patients with chronic hepatitis C
by: Caroline Manchiero, et al.
Published: (2017-12-01) -
More Evidence for the Genetic Susceptibility of Mexican Population to Nonalcoholic Fatty Liver Disease through PNPLA3
by: Paulina Chinchilla-López, et al.
Published: (2018-03-01)